<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04990336</url>
  </required_header>
  <id_info>
    <org_study_id>ZDWY.XHNK.003</org_study_id>
    <nct_id>NCT04990336</nct_id>
  </id_info>
  <brief_title>Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis</brief_title>
  <official_title>Comparison of Clinical Efficacy of Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fifth Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fifth Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A large number of clinical studies have shown that oral administration, external application&#xD;
      or enema of Chinese medicine can promote the recovery of gastrointestinal function and the&#xD;
      absorption of pancreatic inflammation. The aims of the study is to explore the application of&#xD;
      Dachaihu Decoction Compound (DDC)and Rhubarb Single Medicine (RSM) in the Treatment of Acute&#xD;
      Pancreatitis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Significant and effective rate</measure>
    <time_frame>7 days</time_frame>
    <description>Significant and effective rate after 7 days of treatment</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">306</enrollment>
  <condition>Acute Pancreatitis</condition>
  <arm_group>
    <arm_group_label>DDC(Dachaihu decoction compound) Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treated with Dachaihu decoction compound and regular therapies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSM(rhubarb single medicine) Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treated with rhubarb single medicine and regular therapies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>N Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Treated with regular therapies and without traditional Chinese medicine</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Dachaihu decoction compound</intervention_name>
    <description>Dachaihu decoction compound includes Bupleurum, Rhubarb, Citrus aurantium, Scutellaria, Pinellia, White Peony, Jujube, Ginger.</description>
    <arm_group_label>DDC(Dachaihu decoction compound) Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rhubarb single medicine</intervention_name>
    <description>Rhubarb single medicine</description>
    <arm_group_label>RSM(rhubarb single medicine) Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Regular therapies</intervention_name>
    <description>Regular therapies, such as fluid therapy, for acute pancreatitis</description>
    <arm_group_label>DDC(Dachaihu decoction compound) Group</arm_group_label>
    <arm_group_label>N Group</arm_group_label>
    <arm_group_label>RSM(rhubarb single medicine) Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age from 18 to 65 years old&#xD;
&#xD;
          -  Meet the diagnostic criteria of western medicine for acute pancreatitis, within 48&#xD;
             hours of onset&#xD;
&#xD;
          -  Consent of the subjects, who sign the informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who are pregnant or breastfeeding&#xD;
&#xD;
          -  Acute abdomen such as organic intestinal obstruction, gastrointestinal perforation,&#xD;
             purulent cholangitis, etc.&#xD;
&#xD;
          -  Patients with a history of severe heart, liver, kidney and other important organ&#xD;
             diseases&#xD;
&#xD;
          -  Patients with mental illness and malignant tumors&#xD;
&#xD;
          -  People who have allergies, or are allergic to a certain drug ingredient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 27, 2021</study_first_submitted>
  <study_first_submitted_qc>July 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Pancreatitis</keyword>
  <keyword>Dachaihu Decoction Compound</keyword>
  <keyword>Rhubarb Single Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

